The Microbiome Movement Drug Development Europe covers topics such as:
Building a Leading Microbiome Company: How to put Your Foot Firmly in the European Market
Developing Microbiome Based Therapeutics: Leveraging Technology and Product Innovation to Develop Characterization Plans
How to Turn Outstanding Microbiome Science into an Effective & Efficient Product
GxP Sequencing Services & The Future of Microbiome Analysis
Overcoming Preclinical Challengesa
Establishing The First WHO International Reference Reagents for Microbiome Analysis
Engineered Enzymes Precisely Modifying Bile Acids, Treating Non Alcoholic Fatty Liver Disease (NAFLD) and Hyperlipidemia
Evaluating a Next Generation LBP Therapy for Patients with Dravet and ALS
Exploring the Latest Clinical Developments
Developing Microbiome Ecosystem Therapies Aiming to Improve Outcomes for Patients with Liquid Tumours
The benefits of the Capsugel® Enprotect® capsule for your Future Product Development
MH002, a 6-strain Optimized Consortium in Clinical Development for Ulcerative Colitis & Pouchitis
Microbiota in the ICU, Can We Anticipate New Targets?
A High-Throughput Screening Approach to Study Effects of a Multi-Strain Product in the Colon Using Rapid Metabolic Fingerprintingt
Rationally Designed LBPs- From Computational & Pre-clinical Data to Clinical Studies
The Leading CDMO for Live Biotherapeutic Products, Biose Was Founded Over 70 Years Ago and Has Been Manufacturing Bacteria As a Drug Under GMP Conditions Since Then. Heres’ a Few FACTs:
Potency, Dosing, Safety, Toxicology & More: Ensuring Your Preclinical Trial Will Reach Endpoints
Working With Microbiome Investors
Expanding our knowledge of Microbiome Derived Therapeutics
Start-up Landscape: Ensuring the Population Stays High
Getting Right Data That Allows for a Partnership for Biotech Companies
Drinks Reception
How Have Organisations Navigated Their Regulatory Path?
The Power of PoC: Quick Insights Into the Unknown
Exploring the EU Proposal for a New SoHO Regulation and the Impact on Microbiome-based Medicinal Product Development
Benefits of Single-Use vs. Stainless Steel Fermentation Technologies
Technology Challenges of Co-Cultivation
CORAL® Platform as Engine for Design of Optimized Consortia Therapeutics – Therapeutic Program in Spondyloarthritis
PharmaBiome NicheMap™: Deciphering the Interactions That Shape Microbiomes. Bringing
Microbiome meets Spatial Transcriptomics
The Microbiome Drug Development Searchlight Network is Challenging Traditional Thinking with how Drug Development is Done in the Microbiome Space
Examining Development & Manufacturing Approaches: Implications on the Long-Term Impact
The Potential of Using CRISPR Technology for Microbial Gene Therapy
Reprogramming the Microbiome in Cancer Immunotherapy
Microbiome Therapeutics: Key Challenges in Market Access
The Microbiome and Antibiotic Resistance: Opportunities for the Microbiome Business Plan
Landscape Review and Future Outlooks of Microbiome Therapeutics
The Microbiome Movement Drug Development Europe might be held in Jan 2025.
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept", you consent to our use of cookies. You can manage your preferences or learn more by clicking "Customize" or visiting our Cookies Policy page.